COM:SYNOXTHERAPEUTICS
SynOx Therapeutics
- Privately Held
locale
Irelandmarket
PRIVATEindustry
Biopharmaceuticalswebsite
synoxtherapeutics.comcrunchbase
synox-therapeuticslinkedin
synox-therapeuticsfounding date
Jan 01, 2020
SynOx Therapeutics is solely focused on developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for the treatment of tenosynovial giant cell tumours (TGCT) and other macrophage-driven pathologies. The company's mission is to establish emactuzumab as a best-in-class drug of choice to address unmet needs and improve the quality of life for as many patients as ...Show More